344 related articles for article (PubMed ID: 15849193)
1. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.
Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R
J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic mechanisms of Evi-1 protein.
Hirai H; Izutsu K; Kurokawa M; Mitani K
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S35-40. PubMed ID: 11587364
[TBL] [Abstract][Full Text] [Related]
3. Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads.
Candia AF; Watabe T; Hawley SH; Onichtchouk D; Zhang Y; Derynck R; Niehrs C; Cho KW
Development; 1997 Nov; 124(22):4467-80. PubMed ID: 9409665
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
[TBL] [Abstract][Full Text] [Related]
5. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
Dennler S; Itoh S; Vivien D; ten Dijke P; Huet S; Gauthier JM
EMBO J; 1998 Jun; 17(11):3091-100. PubMed ID: 9606191
[TBL] [Abstract][Full Text] [Related]
6. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.
Kato Y; Habas R; Katsuyama Y; Näär AM; He X
Nature; 2002 Aug; 418(6898):641-6. PubMed ID: 12167862
[TBL] [Abstract][Full Text] [Related]
7. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
Pardali K; Kowanetz M; Heldin CH; Moustakas A
J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
9. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O
Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
11. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling.
Izutsu K; Kurokawa M; Imai Y; Maki K; Mitani K; Hirai H
Blood; 2001 May; 97(9):2815-22. PubMed ID: 11313276
[TBL] [Abstract][Full Text] [Related]
12. Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5.
Kahata K; Hayashi M; Asaka M; Hellman U; Kitagawa H; Yanagisawa J; Kato S; Imamura T; Miyazono K
Genes Cells; 2004 Feb; 9(2):143-51. PubMed ID: 15009097
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
14. Developmental expression of Smad1-7 suggests critical function of TGF-beta/BMP signaling in regulating epithelial-mesenchymal interaction during tooth morphogenesis.
Xu X; Jeong L; Han J; Ito Y; Bringas P; Chai Y
Int J Dev Biol; 2003 Feb; 47(1):31-9. PubMed ID: 12653249
[TBL] [Abstract][Full Text] [Related]
15. Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription.
Leong GM; Subramaniam N; Figueroa J; Flanagan JL; Hayman MJ; Eisman JA; Kouzmenko AP
J Biol Chem; 2001 May; 276(21):18243-8. PubMed ID: 11278756
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer.
Jonk LJ; Itoh S; Heldin CH; ten Dijke P; Kruijer W
J Biol Chem; 1998 Aug; 273(33):21145-52. PubMed ID: 9694870
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
18. Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.
Nagarajan RP; Chen F; Li W; Vig E; Harrington MA; Nakshatri H; Chen Y
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):591-6. PubMed ID: 10839991
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
20. The role of FAST-1 and Smads in transcriptional regulation by activin during early Xenopus embryogenesis.
Yeo CY; Chen X; Whitman M
J Biol Chem; 1999 Sep; 274(37):26584-90. PubMed ID: 10473623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]